Cerebral Small Vessel Disease-Related Dementia: More Questions Than Answers

Area of Science:

• Neurology
• Geriatrics
• Radiology

Background:

• Cerebral small vessel disease (CSVD) is increasingly recognized as a significant contributor to age-dependent neurological disorders.
• CSVD is a major cause of stroke and dementia, impacting a growing segment of the aging population.
• Effective recognition, understanding, and treatment strategies for CSVD-related dementia are urgently needed.

Purpose of the Study:

• To review evolving diagnostic criteria and imaging biomarkers for CSVD-related dementia.
• To discuss diagnostic challenges, including mixed pathologies and the lack of specific biomarkers.
• To examine CSVD as a risk factor for neurodegenerative diseases and its underlying mechanisms of brain injury.

Main Methods:

• Literature review of diagnostic criteria and imaging biomarkers for CSVD-related dementia.
• Analysis of evidence linking CSVD to neurodegenerative diseases and brain injury mechanisms.
• Summary of studies on cardiovascular medications for CSVD-related cognitive impairment.

Main Results:

• Evolving diagnostic criteria and imaging biomarkers for CSVD-related dementia are presented.
• Diagnostic challenges, especially with mixed pathologies, are highlighted.
• CSVD is confirmed as a risk factor for neurodegenerative diseases, with potential mechanisms for progressive brain injury outlined.

Conclusions:

• Increased focus on CSVD offers a clearer path toward addressing future challenges posed by this condition.
• Further research is needed to overcome diagnostic hurdles and develop effective treatments for CSVD-related cognitive impairment.
• Cardiovascular medicines show potential relevance for managing CSVD-related cognitive decline.